PuSH - Publikationsserver des Helmholtz Zentrums München: Causal assessment of serum urate levels in cardiometabolic diseases through a mendelian randomization study.

Informationen

Hinweise zu Qualitätskriterien von Zeitschriften

Open-Access-Richtlinie der Helmholtz-Gemeinschaft 2016

CC Licencences

Metriken für Publikationen

Navigation

Startseite

English

EVA: Veröffentlichen

Neuer EVA Antrag

Recherche

Erweiterte Suche

Durchblättern nach ...

... HMGU-Autoren/Konsortien

... Organisationsstruktur

... Zeitschriften

... Publikationstypen

... Forschungsdaten

... Arbeitsgruppen

... Erscheinungsjahr

Publikationen im Überblick

Statistik

HGF Fortschrittsbericht

OA Publikationen

Eintragen

Neue Publikation eintragen

Neue Publikation holen aus...

...EVA

Fehlende Publikation melden

Highlights

Suche

Hilfe & Kontakt

Ansprechpartner

Hilfe

Datenschutz

Helmholtz Open Science

Bibliometrische Indikatoren

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Keenan, T.* ; Zhao, W.* ; Rasheed, A.* ; Ho, W.K.* ; Malik, R.* ; Felix, J.F.* ; Young, R.* ; Shah, N.* ; Samuel, M.A.* ; Sheikh, N.* ; Mucksavage, M.L.* ; Shah, O.* ; Li, J.* ; Morley, M.* ; Laser, A. ; Mallick, N.H.* ; Zaman, K.S.* ; Ishaq, M.* ; Rasheed, S.Z.* ; Memon, F.U.* ; Ahmed, F.* ; Hanif, B.* ; Lakhani, M.S.* ; Fahim, M.* ; Shardha, N.K.* ; Ahmed, N.* ; Mahmood, K.* ; Iqbal, W.* ; Akhtar, S.* ; Raheel, R.* ; O'Donnell, C.J.* ; Hengstenberg, C.* ; Marz, W.* ; Kathiresan, S.* ; Samani, N.* ; Goel, A.* ; Hopewell, J.C.* ; Chambers, J.* ; Cheng, Y.C.* ; Sharma, P.* ; Yang, Q.* ; Rosand, J.* ; Boncoraglio, G.B.* ; Kazmi, S.U.* ; Hakonarson, H.* ; Köttgen, A.* ; Kalogeropoulos, A.* ; Frossard, P.* ; Kamal, A.K.* ; Dichgans, M.* ; Cappola, T.P.* ; Reilly, M.P.* ; Danesh, J.* ; Rader, D.J.* ; Voight, B.F.* ; Saleheen, D.*

Causal assessment of serum urate levels in cardiometabolic diseases through a mendelian randomization study.

J. Am. Coll. Cardiol. 67, 407-416 (2016)

Verlagsversion

DOI

PMC

	Closed

Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.

Abstract
Metriken
Zusatzinfos

BACKGROUND: Although epidemiological studies have reported positive associations between circulating urate levels and cardiometabolic diseases, causality remains uncertain. OBJECTIVES: Through a Mendelian randomization approach, we assessed whether serum urate levels are causally relevant in type 2 diabetes mellitus (T2DM), coronary heart disease (CHD), ischemic stroke, and heart failure (HF). METHODS: This study investigated 28 single nucleotide polymorphisms known to regulate serum urate levels in association with various vascular and nonvascular risk factors to assess pleiotropy. To limit genetic confounding, 14 single nucleotide polymorphisms exclusively associated with serum urate levels were used in a genetic risk score to assess associations with the following cardiometabolic diseases (cases/controls): T2DM (26,488/83,964), CHD (54,501/68,275), ischemic stroke (14,779/67,312), and HF (4,526/18,400). As a positive control, this study also investigated our genetic instrument in 3,151 gout cases and 68,350 controls. RESULTS: Serum urate levels, increased by 1 SD due to the genetic score, were not associated with T2DM, CHD, ischemic stroke, or HF. These results were in contrast with previous prospective studies that did observe increased risks of these 4 cardiometabolic diseases for an equivalent increase in circulating urate levels. However, a 1 SD increase in serum urate levels due to the genetic score was associated with increased risk of gout (odds ratio: 5.84; 95% confidence interval: 4.56 to 7.49), which was directionally consistent with previous observations. CONCLUSIONS: Evidence from this study does not support a causal role of circulating serum urate levels in T2DM, CHD, ischemic stroke, or HF. Decreasing serum urate levels may not translate into risk reductions for cardiometabolic conditions.

Impact Factor

Scopus SNIP

Web of Science
Times Cited

Scopus
Cited By

Altmetric

17.759

5.140

104